Alpha 2.0
Login Register
» Journals » J Cancer Res Ther

Journal of Cancer Research and Therapeutics

The Journal of Cancer Research and Therapeutics is a peer-reviewed publication dedicated to advancing the understanding and treatment of cancer. It provides a platform for researchers, clinicians, and scientists to share their latest findings, innovative therapies, and breakthroughs in cancer research. The journal covers a wide range of topics, including cancer biology, genetics, immunotherapy, targeted therapies, clinical trials, and supportive care. With its rigorous review process and high-quality articles, the journal serves as a valuable resource for the global cancer research community.
Details
Abbr. J Cancer Res Ther
Start 2005
End Continuing
Frequency Quarterly
p-ISSN 0973-1482
e-ISSN 1998-4138
Country India
Language English
Specialty Oncology
Metrics
h-index / Ranks: 7207 51
SJR / Ranks: 9977 427
CiteScore / Ranks: 10462 2.10
JIF / Ranks: 6403 1.3
Recent Articles
1.
Successful treatment of epidermal growth factor receptor exon 19 deletion non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: A case report
Li Z, Wang G, Xue G, Wang N, Hu Y, Cao P, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2148-2151. PMID: 39792426
Osimertinib, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), has revolutionized one of the standard most efficient treatments for EGFR mutation-positive non-small cell lung cancer (NSCLC). Osimertinib, a...
2.
Effect of cryoablation on the spatial transcriptomic landscape of the immune microenvironment in non-small cell lung cancer
Zhou J, Wang S, Liu M, Li Z
J Cancer Res Ther . 2025 Jan; 20(7):2141-2147. PMID: 39792425
Background: Cryoablation induces antitumor immune responses. Spatial transcriptomic landscape technology has been used to determine the micron-level panoramic transcriptomics of tissue slices in situ. Methods: The effects of cryoablation on...
3.
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients
Song Y, Zhang Q, Cai Q, Song Y, Zhang L, He P, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2133-2140. PMID: 39792424
Background: Patients with transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) have limited treatment options and poor outcomes. Methods: This phase III study (NCT04236141) evaluated the efficacy and safety of...
4.
Association of diabetes mellitus with long-term prognosis after ablation therapy for patients with hepatocellular carcinoma: A single-center cohort study
Wang N, Shen Q, Zhou P, Wang M, Zhang J, Sheng Y, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2118-2124. PMID: 39792423
Background: This study investigated the clinical efficacy and prognostic factors of ablative treatment in hepatocellular carcinoma (HCC) patients with and without diabetes mellitus (DM). Methods: Retrospective data were collected from...
5.
Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings
Peng D, Xiong L, Luo Y, Chen J, Zheng Y, Zeng X, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2110-2117. PMID: 39792422
Background: Pulmonary sarcomatoid carcinoma (PSC) is a rare lung cancer characterized by early metastasis and invasion. It is predominantly diagnosed at a locally advanced or metastatic stage, hindering the possibility...
6.
Factors retarding enhanced recovery from thermal ablation of liver tumors: A single-center prospective study
Zhang L, Dai F, Zeng Q, He X, Guo N, Chen X, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2103-2109. PMID: 39792421
Purpose: To evaluate the risk factors that may delay enhanced recovery in the ablation of liver tumors. Methods: A total of 310 patients who underwent ultrasound-guided ablation of liver tumors...
7.
Comparison between lymph and non-lymph node resection in patients with stage IA non-small-cell lung cancer: A retrospective study
Lei B, Zhang Z, Li C, Yang J, Peng J, Zhao Y, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2094-2102. PMID: 39792420
Objective: This retrospective study aimed to determine the need for lymph node resection during surgical treatment in patients with stage IA non-small-cell lung cancer (NSCLC). Materials And Methods: A total...
8.
Integrin α6 and integrin β4 in exosomes promote lung metastasis of colorectal cancer
Cong F, Huang J, Wu C, Zhong H, Qiu G, Luo T, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2082-2093. PMID: 39792419
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide. The mechanisms underlying metastasis, which contributes to poor outcomes, remain elusive. Methods: We used the Cancer Genome Atlas...
9.
Characteristics and prognosis of testicular mixed teratoma and seminoma
Li K, Sun F, Fan C
J Cancer Res Ther . 2025 Jan; 20(7):2074-2081. PMID: 39792418
Background: To evaluate the association of demographic and clinicopathological characteristics with the survival of patients with testicular mixed teratoma and seminoma (TMTS). Methods: The data of 3296 eligible patients with...
10.
The ability of contrast-enhanced ultrasound with Sonazoid to differentiate endometrial carcinoma from benign endometrial lesions: A preliminary, prospective, and multicenter clinical study
Li X, Huang Y, Jiang T, Luo H, Dong X, Zhuo T, et al.
J Cancer Res Ther . 2025 Jan; 20(7):2066-2073. PMID: 39792417
Objective: To examine the diagnostic efficacy of contrast-enhanced ultrasound (CEUS) with Sonazoid (Sonazoid-CEUS) for endometrial lesions. Methods: In this prospective and multicenter study, data were collected from 84 patients with...